🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the efficacy and safety of Serplulimab in Combination With Doce...
Status
Unknown
Location
Zhang Zizhen
Start Date
2023-03-01
Trial ID
NCT05769725
Treatments Being Tested
This trial that is investigating a medication called duvelisib in combinati...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2021-10-14
Trial ID
NCT05057247
Triple-negative breast cancer (TNBC) is a special type of breast cancer, en...
Status
Completed
Location
Guangdong general hospital
Start Date
2018-08-01
Trial ID
NCT03243838
Treatments Being Tested
The purpose of this study is to determine the safety and maximum tolerated ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
1997-10
Trial ID
NCT00139243
Treatments Being Tested
We want to compare Taxol given weekly with Taxotere given every 3 week both...
Status
Completed
Location
Ullevål university hospital
Start Date
2005-03
Trial ID
NCT00201435
The main objective of this research is to increase the life expectancy of p...
Status
Recruiting
Location
Institut de Cancérologie de Lorraine
Start Date
2025-01-02
Trial ID
NCT06640725
Treatments Being Tested
This multi-center, open-label, phase II randomized controlled trial is to e...
Status
Suspended
Location
Sun Yat-sen Memorial Hospital
Start Date
2016-09
Trial ID
NCT02897050
This research study is studying an investigational drug, NC318, as a possib...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-06
Trial ID
NCT04430933
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2000-09
Trial ID
NCT00014352
Treatments Being Tested
Patients with resectable adenocarcinoma of stomach or esophagogastric junct...
Status
Terminated
Location
National Cancer Institute
Start Date
2021-07-21
Trial ID
NCT04937738
Treatments Being Tested